Quantinno Capital Management’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.61M Sell
68,549
-2,133
-3% -$89.9K ﹤0.01% 1969
2026
Q2
$3.32M Buy
70,682
+30,724
+77% +$759K ﹤0.01% 1560
2026
Q1
$755K Buy
39,958
+634
+2% +$10.8K ﹤0.01% 2400
2025
Q4
$527K Buy
39,324
+3,582
+10% +$44.3K ﹤0.01% 2374
2025
Q3
$421K Buy
35,742
+18,588
+108% +$173K ﹤0.01% 2172
2025
Q2
$111K Buy
+17,154
New +$113K ﹤0.01% 2492

Other funds holding DFTX

Quantinno Capital Management's DFTX Position: Q3 2026 in Review

Quantinno Capital Management reduced its Definium Therapeutics (DFTX) stake by 3% in Q3 2026, selling an estimated $89.9K and leaving 68,549 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1969.

Quantinno Capital Management first reported a position in DFTX in Q2 2025 and has held it in 6 quarters since. The position peaked at $3.32M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Quantinno Capital Management held 68,549 shares of Definium Therapeutics worth $2.61M as of Q3 2026.
  • Quantinno Capital Management sold 2,133 Definium Therapeutics shares in Q3 2026, an estimated $89.9K.
  • Definium Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1969 holding.
  • Quantinno Capital Management first reported a position in Definium Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • Quantinno Capital Management's Definium Therapeutics position peaked at $3.32M in Q2 2026.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.